ICD-10-CM Billable Code

E70.8

Other disorders of aromatic amino-acid metabolism

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code E70.8 refers to a group of rare metabolic disorders involving aromatic amino acids. These amino acids include phenylalanine, tyrosine, and tryptophan. Normally, our bodies break down these amino acids through specific metabolic pathways. However, in disorders classified under E70.8, these pathways are impaired, leading to abnormal accumulation of certain substances that can affect various organs and systems. While some aromatic amino-acid disorders are well-known, others are grouped under this code due to their rarity and similar metabolic characteristics. Awareness of these conditions is crucial for early diagnosis and understanding potential health implications.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting enzymes responsible for the metabolism of aromatic amino acids Inheritance patterns, typically autosomal recessive, meaning both parents need to pass on the defective gene Deficiency or malfunction of specific enzymes, such as phenylalanine hydroxylase or tyrosine aminotransferase Rare metabolic enzyme defects that disrupt the normal breakdown processes of aromatic amino acids

Key Symptoms: Developmental delays or intellectual disabilities in some cases Distinctive behavior patterns, including irritability or lethargy Alterations in skin or hair pigmentation Poor growth or weight gain Potential neurological issues, such as seizures Elevated levels of aromatic amino acids or their metabolites detectable in blood tests Possible liver dysfunction or abnormalities in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosis of these disorders mainly involves laboratory testing, including blood and urine analyses to measure levels of amino acids and their metabolites. Newborn screening programs may include some aromatic amino-acid disorders. Confirmatory tests often involve genetic analysis to identify specific mutations. A detailed medical history and physical examination can provide additional clues, especially if symptoms are present. Because symptoms can be subtle or vary widely, diagnosis can be challenging and often requires collaboration among metabolic specialists.

Treatment Protocols: Management strategies focus on controlling amino acid intake to prevent accumulation of harmful substances. Dietary adjustments may include limiting foods rich in aromatic amino acids, such as high-protein foods. In some cases, supplementation with specific nutrients, vitamins, or cofactors may be recommended. Regular monitoring of biochemical levels and developmental assessments are crucial. Enzyme replacement therapies or pharmacological interventions are areas of ongoing research, but they are not standard treatments for all cases. Early diagnosis and intervention are vital to reduce potential complications and support normal development.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E70.8 a billable ICD-10 code?
Yes, E70.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E70.8?
Clinical documentation must specify the nature of Other disorders of aromatic amino-acid metabolism and any associated comorbidities for accurate reporting.

Cite this Clinical Reference